Medications for Oligodendroglioma
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Oligodendroglioma.
Found 2 Approved Drugs for Oligodendroglioma
Voranigo
Generic Name
Vorasidenib
Voranigo
Generic Name
Vorasidenib
Form: Tablet
Method of administration: Oral
FDA approval date: August 07, 2024
Classification: Isocitrate Dehydrogenase 1 Inhibitor
VORANIGO is indicated for the treatment of adult and pediatric patients 12 years and older with Grade 2 astrocytoma or oligodendroglioma with a susceptible isocitrate dehydrogenase-1 (IDH1) or isocitrate dehydrogenase-2 (IDH2) mutation, as detected by an FDA-approved test, following surgery including biopsy, sub-total resection, or gross total resection [see Dosage and Administration.
Iopamidol
Brand Names
Isovue 300, Isovue-M, Isovue 200, Isovue 250, Isovue 370
Iopamidol
Brand Names
Isovue 300, Isovue-M, Isovue 200, Isovue 250, Isovue 370
Form: Injection
Method of administration: Intrathecal, Intravenous, Intravascular
FDA approval date: December 31, 1985
Classification: Radiographic Contrast Agent
ISOVUE-M (lopamidol Injection) is indicated for intrathecal administration in adult neuroradiology including myelography (lumbar, thoracic, cervical, total columnar), and for contrast enhancement of computed tomographic (CECT) cisternography and ventriculography. ISOVUE-M 200 (lopamidol Injection) is indicated for thoraco-lumbar myelography in children over the age of two years.
Showing 1-2 of 2
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances